Skip to main content
Terug
Watch Compare

Cabaletta Bio, Inc.

Datakwaliteit: 83%
CABA
NASDAQ Manufacturing Chemicals
€ 3,13
▼ € 0,04 (-1,26%)
Marktkapitalisatie: 345,10 M
Prijs
€ 3,10
Marktkapitalisatie
345,10 M
Dagbereik
—
52-Weeksbereik
—
Volume
—
Openen —
50D / 200D Gem.
—
50D / 200D Gem.
—

Quick Summary

Belangrijkste Punten

Negative free cash flow of -132,31 M

Groei

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
-105,59%
Onder sectorgemiddelde (-54,47%)
ROIC-83,23%
Net MarginN/A
Op. MarginN/A

Veiligheid

Debt / Equity
N/A
Current Ratio3,60
Interest Coverage-85,95

Waardering

PE (TTM|NTM)
-2,06 | -2,23
Onder sectorgemiddelde (-1,49)
P/B Ratio2,47
EV/EBITDAN/A
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Manufacturing sector mediaan (1385 peers)
Metriek Aandeel Sector Mediaan
P/E -2,1 -1,5
P/B 2,5 1,6
ROE % -105,6 -54,5
Net Margin % — -41,5
Rev Growth 5Y % — 1,9
D/E — 0,3

Koersdoel Analisten

8 analisten
Buy
Huidig
€ 3,13
+319.3%
Koersdoel
€ 13,13
€ 2,00
€ 13,50
€ 30,00
Vooruitzicht
Forward K/W -2,23
Forward WPA -€ 1,40
Omzet Sch. 0,0

Winstschattingen

Periode WPA Sch. Omzet Sch. Analisten
FY2027 -€ 1,40
-€ 2,63 – -€ 0,84
 0,0 5
FY2026 -€ 1,52
-€ 2,13 – -€ 1,00
 0,0 5

Winstverassingen

Laatste 4 kwartalen
Kwartaal Geschat WPA Werkelijk WPA Verrassing
Q42025 -€ 0,47 -€ 0,40 +14,1%
Q32025 -€ 0,46 -€ 0,44 +3,9%
Q22025 -€ 0,61 -€ 0,73 -19,4%
Q12025 -€ 0,66 -€ 0,71 -7,4%

ETFs Holding This Stock

JMIGX JMIGX
0,65% weight
JMCGX JMCGX
0,65% weight
PHLQX PHLQX
0,19% weight
PHLCX PHLCX
0,19% weight
PHLAX PHLAX
0,19% weight
BRSIX BRSIX
0,05% weight
AVSC logo AVSC Avantis U.S. Small Cap Equity ETF
0,00% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -167,86 M
ROE -105,59% ROA -81,04%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -132,31 M
ROIC -83,23% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 3,60
Interest Coverage -85,95 Asset Turnover N/A
Working Capital 118,83 M Tangible Book Value 139,47 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -2,06 Forward P/E -2,23
P/B Ratio 2,47 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -38,34%
Market Cap 345,10 M Enterprise Value 284,89 M
Per Share
EPS (Diluted TTM) -2,10 Revenue / Share N/A
FCF / Share -1,19 OCF / Share -1,18
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 78,82%
SBC-Adj. FCF -154,24 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — — —
Net Income -167,86 M -115,86 M -67,68 M -52,98 M -46,29 M
EPS (Diluted) -2,10 -2,34 -1,65 -1,81 —
Gross Profit — — — — —
Operating Income -172,24 M -125,14 M -74,66 M -54,14 M -46,31 M
EBITDA — — — — —
R&D Expenses 142,67 M 97,20 M 55,42 M 39,30 M 32,49 M
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense 2,00 M 748.000,0 — — —
Income Tax 0,0 — — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 165,08 M 185,05 M 253,65 M 116,97 M 126,34 M
Total Liabilities 53,03 M 32,71 M 17,45 M 12,45 M —
Shareholders' Equity 112,05 M 152,34 M 236,20 M 104,52 M 117,96 M
Total Debt — — — — —
Cash & Equivalents 82,98 M 163,96 M 193,24 M 81,61 M 122,22 M
Current Assets 138,87 M 166,68 M 244,49 M 108,83 M 124,54 M
Current Liabilities 50,15 M 27,09 M 15,99 M 9,49 M 8,38 M